In the BioHarmony Drug Report Database

"Preview" Icon

Choline fenofibrate

Trilipix (choline fenofibrate) is a small molecule pharmaceutical. Choline fenofibrate was first approved as Trilipix on 2008-12-15. Trilipix’s patent is valid until 2025-01-07 (FDA).

 

Trade Name

 

Trilipix
 

Common Name

 

choline fenofibrate
 

ChEMBL ID

 

CHEMBL1201745
 

Indication

 

 

Drug Class

 

Antihyperlipidemics (clofibrate type)

Image (chem structure or protein)

Choline fenofibrate structure rendering